Automated Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells at an Academic Center for a Phase I Clinical Trial in Relapsed, Refractory NHL

被引：0
|
作者：
Zhu, Fenlu [1 ]
Shah, Nirav N. [2 ]
Schneider, Dina [3 ]
Xu, Huiqing [1 ]
Chaney, Katherine [4 ]
Luib, Lawrence [5 ]
Keever-Taylor, Carolyn [6 ]
Dropulic, Boro [3 ]
Orentas, Rimas [7 ]
Hari, Parameswaran [2 ]
Johnson, Bryon D. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, BMT & Cellular Therapy Program, Hematol Oncol, Med, Milwaukee, WI 53226 USA
[3] Lentigen Technol Inc, Gaithersburg, MD USA
[4] Med Coll Wisconsin, Med, Milwaukee, WI 53226 USA
[5] Froedtert Hosp, Milwaukee, WI USA
[6] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[7] Seattle Childrens Hosp, Seattle, WA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I Clinical Trial of Autologous CLL1 CAR-T Therapy for Pediatric Patients with Relapsed and Refractory Acute Myeloid Leukemia
    Bu, Chaoke
    Peng, Zhiyong
    Luo, Min
    Li, Guangchao
    Li, Chunfu
    BLOOD, 2020, 136
  • [42] Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
    Tastan, Cihan
    Kancagi, Derya Dilek
    Turan, Raife Dilek
    Yurtsever, Bulut
    Cakirsoy, Didem
    Abanuz, Selen
    Yilanci, Muhammet
    Seyis, Utku
    Ozer, Samed
    Mert, Selin
    Kayhan, Cavit Kerem
    Tokat, Fatma
    Elmas, Merve Acikel
    Birdogan, Selcuk
    Arbak, Serap
    Yalcin, Koray
    Sezgin, Aslihan
    Kizilkilic, Ebru
    Hemsinlioglu, Cansu
    Ince, Umit
    Ratip, Siret
    Ovali, Ercument
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (04) : 234 - 247
  • [43] Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial
    Ghosn, Mario
    Cheema, Waseem
    Zhu, Amy
    Livschitz, Jennifer
    Maybody, Majid
    Boas, Franz E.
    Santos, Ernesto
    Kim, DaeHee
    Beattie, Jason A.
    Offin, Michael
    Rusch, Valerie W.
    Zauderer, Marjorie G.
    Adusumilli, Prasad S.
    Solomon, Stephen B.
    LUNG CANCER, 2022, 165 : 1 - 9
  • [44] Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma.
    Shah, Nirav Niranjan
    Zhu, Fenlu
    Schneider, Dina
    Taylor, Carolyn
    Krueger, Winfried
    Worden, Andrew
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy
    Johnson, Bryon
    Dropulic, Boro
    Orentas, Rimas
    Hari, Parameswaran
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Phase 1 trial of anti-CD19 chimeric antigen receptor T (CAR-T) cells with tumor necrosis alfa receptor superfamily 19 (TNFRSFI9) transmembrane domain.
    Caimi, Paolo Fabrizio
    Reese, Jane
    Otegbeye, Folashade
    Schneider, Dina
    Chamoun, Kamal
    Boughan, Kirsten M.
    Cooper, Brenda W.
    Galloway, Erin
    Gallogly, Molly
    Kruger, Winfried
    Worden, Andrew
    Kadan, Michael
    Malek, Ehsan
    Metheny, Leland L.
    Tomlinson, Benjamin K.
    Sekaly, Rafick-Pierre
    Wald, David
    Orentas, Rimas
    Dropulic, Boro
    De Lima, Marcos J. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
    Zhou, Xuan
    Tu, Sanfang
    Wang, Chunsheng
    Huang, Rui
    Deng, Lan
    Song, Chaoyang
    Yue, Chunyan
    He, Yanjie
    Yang, Jilong
    Liang, Zhao
    Wu, Anqin
    Li, Meifang
    Zhou, Weijun
    Du, Jingwen
    Guo, Zhenling
    Li, Yongqian
    Jiao, Cheng
    Liu, Yuchen
    Chang, Lung-Ji
    Li, Yuhua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [47] The CD19 Chimeric Antigen Receptor Re-directs CMV Specific T Cells Derived From Central Memory T Cells (Bi-specific T Cells) Against Human Acute Lymphoid Leukemia (ALL)
    Wang, Xiuli
    Wong, Winnie
    Chang, Wen-Chung
    Ostberg, Julie R.
    DiGiusto, David
    Jensen, Michael C.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 926 - 927
  • [48] Sequential anti-CD19, anti-CD22, and anti-CD20 autologous chimeric antigen receptor T cell (CAR-T) therapies treating a child with relapsed refractory Burkitt lymphoma
    Du, Juan
    Zhang, Yonghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [49] Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients
    Yajun Zhang
    Zhiwei Zhang
    Yongmei Ding
    Yuan Fang
    Pei Wang
    Wenqi Chu
    Zhenlin Jin
    Xintao Yang
    Jiangtao Wang
    Jinxing Lou
    Qijun Qian
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3725 - 3734
  • [50] Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas
    Chang, Lung-Ji
    Li, Yuhua
    Tu, Sanfang
    Lai, Xun
    Huang, Rui
    Tsao, Shih-Ting
    Liu, Yu-Chen
    Zhang, Rui
    Deng, Lan
    Zhou, Xuan
    Zhang, Hongyu
    Zhang, Wenli
    Li, Yuchen
    BLOOD, 2018, 132
12345